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In mouse skeletal muscles, Pax7 uniquely marks
muscle satellite cells and plays some important
yet unknown functions at the perinatal stage. To
elucidate its in vivo functions, we initiated a yeast
two-hybrid screening to look for Pax7-interacting
proteins and identified a previously uncharacterized
Pax7- and Pax3-binding protein (Pax3/7BP). Pax3/
7BP is a ubiquitously expressed nuclear protein,
enriched in Pax7+ muscle precursor cells (MPCs),
and serves as an indispensable adaptor for Pax7 to
recruit the histone 3 lysine 4 (H3K4) methyltransfer-
ase (HMT) complex by bridging Pax7 and Wdr5.
Knockdown of Pax3/7BP abolished the Pax3/7-
associated H3K4 HMT activity and inhibited the
proliferation of Pax7+ MPCs from young mice both
in culture and in vivo. Id3 and Cdc20 were direct
target genes of Pax7 and Pax3/7BP involved in the
proliferation of Pax7+ MPCs. Collectively, our work
establishes Pax3/7BP as an essential adaptor linking
Pax3/7 with the H3K4 HMT to regulate the prolifera-
tion of MPCs.
INTRODUCTION
Two similar but distinct waves of myogenesis exist in verte-
brates: embryonic myogenesis and adult myogenesis. In mice,
the former starts with muscle precursor cells (MPCs) in the
myotome around embryonic day 8 with the expression of
Myf5, one of the four myogenic regulatory factors (MRFs) (Puri
and Sartorelli, 2000; Sabourin and Rudnicki, 2000; Tapscott,
2005), while the latter is executed by muscle stem cells, also
called muscle satellite cells (MSCs), which originate from the
central region of the dermomyotome with the expression of
Pax7 and Pax3 (Ben-Yair and Kalcheim, 2005; Gros et al.,C2005; Kassar-Duchossoy et al., 2005; Relaix et al., 2005). In adult
muscles, MSCs are quiescent, located between basal lamina
and the sarcolemma of myofibers, and are mainly responsible
for postnatal muscle growth and muscle regeneration in
response to either injury or exercise (Biressi and Rando, 2010;
Buckingham and Relaix, 2007; Le Grand and Rudnicki, 2007;
Wagers and Conboy, 2005; Zammit, 2008).
In the past decade, intensive efforts have been made to char-
acterize MSCs at the molecular level. A major breakthrough in
this regard came with the discovery of Pax7 as a specific marker
for all MSCs (Seale et al., 2000). Pax3, a close paralog of Pax7, is
also coexpressed in MSCs of a subset of muscles including the
diaphragm (Relaix et al., 2005, 2006). Both Pax7 and Pax3 are
transcription factors of the Pax family proteins and contain
a characteristic set of domains, including a paired domain
(PD), an octapeptide motif, and a homeodomain (HD) (Bucking-
ham and Relaix, 2007; Lang et al., 2007) (Figure 1A). While the
PD and HD domains in Pax proteins are mainly involved in
DNA binding, both of them and the octapeptide are also capable
of interacting with other proteins (Buckingham and Relaix, 2007;
Lang et al., 2007). Although Pax7 is also known to be expressed
in other nonmuscle tissues, Pax7 only uniquely marks MSCs in
skeletal muscles (Seale et al., 2000). In addition to the quiescent
MSCs (i.e., Pax7+/MyoD), Pax7 is also expressed in activated
and proliferating myoblasts (i.e., Pax7+/MyoD+) that are also
called MPCs. However, upon differentiation, Pax7 is rapidly
downregulated (Olguin and Olwin, 2004; Zammit et al., 2004).
The number of MSCs/MPCs was found to be comparable in
newborn mice with or without Pax7 (Oustanina et al., 2004;
Relaix et al., 2006). Intriguingly, the Pax7 null MSCs quickly dis-
appeared in adult mice (Kuang et al., 2006; Oustanina et al.,
2004; Relaix et al., 2006). While one report showed that Pax7
null MSCs were prone to apoptosis (Relaix et al., 2006), another
suggested that Pax7 null MSCs failed to establish quiescence
and underwent precocious differentiation (Lepper et al., 2009).
The importance of Pax7 in MSCs is further underscored by the
findings that in a few Pax7 null mice that survived to adulthood,
there was a major defect in injury-induced muscle regeneration
(Kuang et al., 2006; Oustanina et al., 2004; Relaix et al., 2006).ell Stem Cell 11, 231–241, August 3, 2012 ª2012 Elsevier Inc. 231
Figure 1. Pax3/7BP Is a Pax7-Interacting Protein
(A) A schematic diagram of the full-length and the truncated mouse Pax7 used
in the yeast two-hybrid (Y2H) screening. PD, paired domain; O, Octapeptide;
HD, homeodomain.
(B) Five-hundred micrograms of whole cell extract (WCE) prepared from trunk
muscles of P5 mice were immunoprecipitated (IP) with polyclonal antibodies
against either Pax3/7BP or JAK2 and the coprecipitated Pax7 and Pax3 was
revealed by western blot (WB) analysis. Fifty micrograms of WCE was used as
the input control.
(C) C2C12 cells were cotransfected with a Pax7 construct together with
various Pax3/7BP constructs as indicated. Flag-tagged Pax3/7BP proteins
were immunoprecipitated from an equal amount (300 mg) of WCE, and the
coprecipitated Pax7 was revealed by WB analysis. Thirty micrograms of WCE
was used as the input. n.s., nonspecific.
(D) A schematic summary of Pax3/7BP fragments in different Pax7-binding
assays. Co-IP, coimmunoprecipitation assays; Y2H, yeast two-hybrid assays;
N/A, not assayed.
(E) 293T cells were transfected with Pax7 together with PIP5Kg (control) or
different Pax3/7BP constructs. Flag-tagged proteins were immunoprecipi-
tated from WCE and the coprecipitated Pax7 was detected by WB analysis.
FL, full-length. See also Figure S1.
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completely dispensable for the maintenance or survival of
MSCs and for injury-induced muscle regeneration in adult mice
(Lepper et al., 2009). However, Pax7 was found to play a critical
role in MSCs/MPCs in young mice (i.e., those younger than
3 weeks old) (Lepper et al., 2009). It remains unclear what role
Pax7 plays in MSCs or MPCs in young mice.
To elucidate the function of Pax7 in vivo, it would be very help-
ful to identify Pax7-interacting proteins. Using C2C12 myoblasts
stably expressing Pax7 and combining immunoprecipitation
withmass spectrometry, McKinnel et al. showed that Pax7 could
recruit the mixed-lineage leukemia (MLL)-containing histone
methyltransfearse (HMT) complex that specifically catalyzes
dimethylation and trimethylation of lysine 4 in histone 3 (H3K4)
(McKinnell et al., 2008). The MLL-containing HMT is frequently
recruited to the regulatory regions of the transcription-active
genes (Ansari and Mandal, 2010; Cosgrove and Patel, 2010;
Malik and Bhaumik, 2010; Shilatifard, 2008). The H3K4 HMT
complex consists of a set of core components including a
catalytic protein of the MLL family, Wdr5, Rbbp5, and Ash2L
(Dou et al., 2006). It is unclear whether Pax7 directly interacts
with any of the core components of the MLL complex. To look
for direct Pax7-binding proteins, we conducted a yeast two-
hybrid screening using Pax7 as bait, and we identified a previ-
ously uncharacterized Pax7- and Pax3-binding protein (Pax3/
7BP). We provide evidence here to show that Pax3/7BP bridges
Pax7 and Wdr5 to facilitate the recruitment of the H3K4 HMT
complex to the regulatory regions of Pax7 target genes. Both
Pax7 and Pax3/7BP play key roles in regulating the proliferation
of Pax7+ MPCs. Cdc20 and Id3 are direct target genes of Pax7
and Pax3/7BP involved in regulating the proliferation of MPCs.
Our work suggests that Pax3/7BP could serve as an adaptor
protein linking the H3K4 HMT complex to selected transcription
factors and participate in epigenetic regulation of their target
genes.
RESULTS
Pax3/7BP Is a Pax7- and Pax3-Interacting Protein
To better understand how Pax7 exerts its functions in MSCs/
MPCs, we decided to search for Pax7-interacting proteins
using yeast two-hybrid screening. For reasons unknown, among
several Pax7 bait constructs we generated, including the full-
length Pax7, only Pax7 (aa 27–208) that spans the entire PD
and the octapeptidemotif (O) was expressed in yeast (Figure 1A).
We then used this fragment as bait to screen a mouse 17-day
embryo cDNA library. Among 31 positive clones identified in
our screening, most of them encoded members of the fibulin
family (our unpublished data), which are all extracellular proteins.
Because Pax7 is a nuclear transcription factor, we reasoned
that its interacting protein should also be a nuclear protein. By
name, one positive clone from our screen fit the criterion: it
encodes GC-rich sequence DNA binding factor 1 (GCFC1,
NP_080386.3), a protein of 919 amino acids that is conserved
in metazoa and has not been functionally characterized in
any previous publications. Because the sequence in the Pax7
fragment used as bait is highly conserved in Pax3 (Fig-
ure S1A,available online), we also tested whether the corre-
sponding fragment in Pax3 interacted with the GCFC1 clone
Figure 2. Pax3/7BP Is a Nuclear Protein Enriched in Primary
Myoblasts
(A) Total RNA was isolated from different mouse tissues and subjected to
semiquantitative RT-PCR analysis to detect Pax3/7BP mRNA. GAPDH: the
glyceraldehyde 3-phosphate dehydrogenase gene.
(B) C2C12 cells were transfected with a plasmid encoding Myc-Pax3/7BP.
Twenty-four hours after transfection, the cells were fixed and subjected to
immunostaining using an anti-Myc antibody. The arrowheads indicated the
nuclei that were double-positive for DAPI and Myc-Pax3/7BP. Scale bar:
100 mm.
(C) WCE and the cytoplasmic (Cyto) and the nuclear fractions (Nuclear) were
prepared from C2C12 myoblasts and separated on SDS-PAGE, followed by
WB analysis with the indicated antibodies.
(D) Total RNA isolated from either primary myoblasts or mature tibialis anterior
muscles was subjected to RT-qPCR analysis to reveal the relative mRNA
levels of Pax7, Myf5, and Pax3/7BP with GAPDH as the internal control. The
fold change was calculated as the ratio of the relative amount of an mRNA in
primary myoblasts over that in mature muscles. Data were presented as
mean ± SD.
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specifically interacted with GCFC1 in yeast two-hybrid assays.
Because there is no direct evidence showing that GCFC1 is
a direct DNA binding protein, the current name in the database
of the National Center for Biotechnology Information (NCBI)
could be confusing. Therefore, we renamed this protein Pax3/
7-binding protein or Pax3/7BP. To facilitate our work, we gener-
ated two polyclonal antibodies against Pax3/7BP: one was
found to be good for immunoblotting, while the other was suit-
able for immunoprecipitation (Figures S1C and S1D). To confirm
whether Pax3/7BP interacts with Pax7 or Pax3 under physiolog-Cical conditions, we performed coimmunoprecipitation assays
using lysates from trunk muscles of 5-day-old (P5) mice in which
Pax7, Pax3, and Pax3/7BP are all known to be expressed (Relaix
et al., 2005, 2006; Seale et al., 2000). We found that both the
endogenous Pax7 and Pax3 preferentially coprecipitated with
Pax3/7BP but not JAK2 (a negative control) (Figure 1B). We
next tried to map the Pax7-interacting domain in Pax3/7BP.
We generated a series of deletion constructs of Pax3/7BP. By
combining both coimmunoprecipitation and yeast two-hybrid
assays, we found that a region of Pax3/7BP that spans aa
380–560 was both necessary and sufficient to interact with
Pax7 (Figures 1C–1E).
Pax3/7BP Is a Nuclear Protein Enriched in MPCs
To functionally characterize Pax3/7BP, we first checked its
tissue expression profile. By semiquantitative RT-PCR, we found
that the Pax3/7BP mRNA was ubiquitously expressed in all
tissues examined including skeletal muscles (Figure 2A). To
examine the subcellular localization of Pax3/7BP, we performed
immunostaining assays. In C2C12 cells transfected with a Myc-
Pax3/7BP-expressing construct, we found that Pax3/7BP was
exclusively localized in the nuclei of C2C12 cells (Figure 2B).
To further verify this result, we separated the soluble whole cell
extract (WCE) of C2C12 myoblasts into the cytoplasmic and
nuclear fractions. Consistently, we found that the endogenous
Pax3/7BP was predominantly localized in the nuclear fraction
(Figure 2C). To examine whether Pax3/7BP is expressed in
Pax7+ MPCs, we isolated total RNA from both tibialis anterior
(TA) muscles of adult mice and freshly isolated Pax7+ MPCs
and performed quantitative RT-PCR. After normalizing the
mRNA levels of Pax3/7BP to those of glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), we found that the Pax3/
7BP mRNA was highly enriched in MPCs instead of mature
muscles, the latter consisting of a large quantity of differentiated
myofibers and a small fraction of quiescent MSCs/MPCs
(Figure 2D). This differential expression pattern of Pax3/7BP
in MPCs and mature muscles was similar to that of Pax7 and
Myf5 (Figure 2D), both of which are known to be enriched in
MSCs/MPCs (Beauchamp et al., 2000; Seale et al., 2000).
Pax3/7BP Is Associated with the H3K4 HMT Complex
through Wdr5
To understand the physiological relevance of the interaction
between Pax7 and Pax3/7BP, we turned to a recent finding
that Pax7 could recruit the H3K4 HMT in myoblasts (McKinnell
et al., 2008). Interestingly, we noticed that the domain of Pax7
involved in recruiting HMT overlapped with what was used in
our yeast two-hybrid screening. Thus, we tested if Pax3/7BP
was also associated with the HMT complex. The WCE prepared
from muscles of P5 young mice were subjected to immunopre-
cipitation with various antibodies against key components of
the H3K4 HMT complex. As shown in Figure 3A, we found that
Pax3/7BP specifically coprecipitated with Wdr5, Rbbp5,
Ash2L, and different catalytic subunits of the H3K4 HMT
complex: Set1, Set2, and MLL1–4, but not with a control anti-
body. Furthermore, by direct H3methylation assays, we demon-
strated that the full-length Pax3/7BP immunoprecipitated from
C2C12 myoblasts displayed HMT activity toward H3 (Figures
3B and S2A). The Pax3/7BP-associated HMT activity wasell Stem Cell 11, 231–241, August 3, 2012 ª2012 Elsevier Inc. 233
Figure 3. Pax3/7BP Interacts with the H3K4 HMT Complex through Wdr5
(A) One milligram of WCE from muscles of P5 mice was subjected to immunoprecipitation using various antibodies as indicated. The coprecipitated Pax3/7BP
was revealed by WB analysis.
(B–D) C2C12 cells were transfected with various plasmids as indicated. An equal amount of WCE (500 mg) was subjected to immunoprecipitation using either the
anti-HA or anti-Flag antibody. The immunoprecipitates were subjected to in vitro HMT assays with the recombinant histone H3 as a substrate. The reaction
mixtures were separated on SDS-PAGE followed by gel drying and fluorography (B and D) or WB analysis (C). K4Q, a mutant H3 with K4 replaced by Q; FL, full-
length. Me1, Me2, and Me3 denote the monomethylated, dimethylated, or trimethylated H3K4, respectively.
(E) WCE was prepared from C2C12 cells transfected with various siRNAs. Wdr5 was immunoprecipitated from 500 mg of WCE and the immunoprecipitates were
subjected to in vitro HMT assays toward H3. In (D and E), after fluorography (top panel), the dried gel was rehydrated and stained with Coomassie blue to reveal
the amount of H3 used in each reaction (second panel). Fifty micrograms of input WCE was subjected to WB analysis with indicated antibodies.
(F) Pairs of in vitro translated proteins (left panel) were mixed as indicated, followed by immunoprecipitation with the anti-Flag antibody. The coprecipitated
protein was revealed by WB analysis (right panel). See also Figure S2.
Cell Stem Cell
Pax3/7BP Bridges Pax3/7 and Wdr5comparable to that associated with Pax7, Pax3, or SMYD2,
another HMT specific for H3K36 (Shilatifard, 2008). Small N- or
C-terminal deletion of Pax3/7BP [i.e., Pax3/7BP (aa 175–919)
and Pax3/7BP (aa 1–820)] reduced, but not completely elimi-
nated, its associated HMT activity. However, a larger C-terminal
truncation in Pax3/7BP [i.e., Pax3/7BP (aa 1–662) and Pax3/7BP
(aa 1–560)] completely abolished its associated HMT activity
(lanes 7 and 8). Because Pax3/7BP is ubiquitously expressed,
we showed that Flag-Pax3/7BP that was immunoprecipitated
from several nonmuscle cell lines, like COS7, 293T, or NIH
3T3, also displayed HMT activity (Figure S2B). Furthermore,
using antibodies specifically recognizing monomethylated, di-
methylated or trimethylated H3, we showed that Pax3/7BP,
just like Pax7, mainly associated with the HMT that catalyzes
dimethylation or trimethylation of H3 (Figure 3C). Using an
H3K4Q mutant protein, we also further confirmed that the HMT
that was associated with either Pax3/7BP or Pax7 was specific234 Cell Stem Cell 11, 231–241, August 3, 2012 ª2012 Elsevier Inc.for H3K4 (Figure 3D). In contrast, SMYD2, an HMT specific for
H3K36, methylated both the wild-type H3 and the H3K4Q
mutant. We then tested whether Pax3/7BP is a key component
of the H3K4 HMT complex. We transfected C2C12 myoblasts
with either a control siRNA against the green fluorescence
protein (GFP) gene or two different siRNAs against Pax3/7BP.
We then immunoprecipitated Wdr5, a core component of the
H3K4 HMT complex (Dou et al., 2006; Wysocka et al., 2005),
from these C2C12 myoblasts and measured its associated
HMT activity. As shown in Figure 3E, knockdown of Pax3/7BP
did not affect the HMT activity associated with Wdr5, suggesting
that Pax3/7BP is not a key component in the H3K4 HMT
complex. To find out which component of the H3K4 HMT
complex interacts with Pax3/7BP, we expressed individual
proteins in rabbit reticulocyte lysates using the coupled in vitro
transcription/translation system and mixed different proteins
together as indicated in Figure 3F. We then immunoprecipitated
Figure 4. Pax3/7BP Bridges Pax7 and the H3K4 HMT Complex
(A) WCE was prepared from C2C12 myoblasts cotransfected with various plasmids and siRNAs as indicated. HA-Pax7 and Flag-Pax3/7BP were immunopre-
cipitated from 500 mg of WCE and the immunoprecipitates were subjected to in vitro HMT assays toward H3. The dried gel was first subjected to fluorography
(top) followed by rehydration and Coomassie blue staining (middle). Fifty micrograms of input WCE was subjected to WB analysis with the indicated antibodies
(bottom).
(B) Primary myoblasts were infected with adenoviruses expressing shRNAs targeting LacZ or Pax3/7BP. One milligram of WCE was subjected to immuno-
precipitation with either an anti-GFP antibody or the anti-Wdr5 antibody. The coprecipitated Pax7 was revealed by WB analysis (top panel). Fifty micrograms of
input WCE was analyzed by WB analysis (bottom panel). See also Figures S3 and S4.
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tive control, we showed that Pax7 coprecipitated with Pax3/7BP
(lane 9). Importantly, we found thatWdr5 (lane 10), but not Rbbp5
or Ash2L (lanes 11 and 12), also coprecipitated with Pax3/7BP.
As a negative control, Pax7 or Wdr5 did not coprecipitate with
PIP5Kg (lanes 7 and 8). Our results showed that Pax3/7BP was
associated with the H3K4 HMT complex through Wdr5.
Pax7-Associated HMT Activity Depends on Pax3/7BP
Because both Pax7 and Pax3/7BP associate with the H3K4
HMT complex, we next asked whether Pax3/7BP serves as an
essential adaptor to link the H3K4 HMT with Pax7. In C2C12
myoblasts, as a positive control, we first showed that both the
Pax7- and Pax3/7BP-associated HMT activity was nearly abol-
ished when Wdr5 was knocked down (Figure 4A, top panel:
lanes 2–3 and 7–8), consistent with the fact that both Pax7 and
Pax3/7BP interact with the H3K4 HMT through Wdr5. Impor-
tantly, we found that the Pax7-associated HMT activity was
also greatly reduced when Pax3/7BP was knocked down (lanes
4 and 5). Our control experiments showed that siRNAs forWdr5
and Pax3/7BP worked well (Figure 4A, bottom two panels).
Similarly, we found that the Pax3-associated HMT activity was
also dependent on Pax3/7BP (Figure S3). To assess whether
Pax3/7BP was required for the recruitment of the HMT complex
by other transcription factors, we examined MEF2, which is
known to associate with the H3K4 complex in differentiating
myocytes (Rampalli et al., 2007). Unlike Pax7, the MEF2-
associated H3K4 HMT activity was not affected by Pax3/7BP
knockdown (Figure S4). Our results suggested that Pax3/7BP
specifically links Wdr5 with Pax7 or Pax3. To directly prove
this, we infected primary myoblasts with adenoviruses express-
ing small-hairpin RNAs (shRNA) specifically targeting either
lacZ (control) or Pax3/7BP, and we showed that Pax3/7BP-
shRNA was effective in knocking down Pax3/7BP (Figure 4B,
bottom panel). When we immunoprecipitated Wdr5 from
myoblast lysates, we found that the endogenous Pax7 onlyCcoprecipitated with Wdr5 in myoblasts infected with the
lacZ-shRNA-expressing adenovirus (Figure 4B, top panel). In
contrast, in myoblasts infected with the Pax3/7BP-shRNA-
expressing adenovirus, Wdr5 failed to coprecipitate Pax7. This
result indicated that the physical binding between Wdr5 and
Pax7 was dependent on Pax3/7BP.
Pax3/7BP Is Involved in Myoblast Proliferation
in Cell Culture
Existing evidence suggested that Pax7 plays a role in myoblast
proliferation (Chen et al., 2010; Oustanina et al., 2004; Palacios
et al., 2010; Relaix et al., 2006). We therefore tested whether
Pax3/7BP is also involved in this process. To address this issue,
we isolated Pax7+ MPCs from P5 mice and expanded them
in vitro. We then transfected the same number of Pax7+ MPCs
with individual siRNAs specifically targeting GFP, Pax7, or
Pax3/7BP. Myoblasts were subjected to two different cell prolif-
eration assays: in the BrdU incorporation assays, after 24 hr of
growth, cells were labeled with BrdU for 30 min before harvest.
Consistently, we found that knockdown of Pax7 indeed reduced
the proliferation of MPCs (Figures 5A and 5B). Interestingly,
knockdown of Pax3/7BP also inhibited myoblast proliferation
to a similar extent. Using theWST-1 assays that directly measure
the activity of the mitochondrial succinate-tetrazolium reduc-
tase, which is proportional to the number of live cells, we
confirmed that the growth of Pax7+ MPCs was inhibited when
either Pax7 or Pax3/7BP was knocked down (Figure 5C). Thus,
our results above showed that Pax3/7BP was required for the
proliferation of Pax7+ MPCs in cell culture.
Pax3/7BP Is Required for the Proliferation of MPCs
In Vivo
Mouse Pax7 was shown to have some essential yet unknown
functions in the first 3 weeks after birth, which is a period when
Pax7+ MPCs undergo extensive proliferation (Lepper et al.,
2009). To find out whether Pax3/7BP also plays a role at thisell Stem Cell 11, 231–241, August 3, 2012 ª2012 Elsevier Inc. 235
Figure 5. Pax3/7BP Is Required for the Proliferation of Primary
Myoblasts in Culture
(A–C) Primary myoblasts were transfected with various siRNAs as indicated
and cultured in the growth medium. (A and B) Twenty-four hours after
transfection, cells were labeled with 10 mM of BrdU for 30 min, then fixated
and immunostained (A). The nuclei were counterstained with DAPI. Scale bar:
100 mm. The percentage of BrdU+ cells was calculated as the ratio of the
number of BrdU+ cells over that of DAPI+ cells and the data were presented
as mean ± SD in (B). (C) Twenty-four hours after transfection, cells were
trypsinized, and an equal number of cells (3,000 cells/well) was replated into
96-well plates. Six duplicates were used for each sample at each time point.
At various time points, the number of live cells in each well was indirectly
quantified by the WST-1 assays. The experiment was done three times with
similar results and the data from one representative experiment were pre-
sented as mean ± SD.
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MAX (Invitrogen) into the TA muscles of young mice at postnatal
days 6, 8, and 10. A GFP siRNA was injected into the contralat-
eral TA muscle to serve as a control. The TA muscles were iso-
lated for further analysis at postnatal day 12. To make sure
that an injected siRNA could knock down its intended target
gene in MPCs, we employed Pax7 siRNA as a positive control.
As shown in Figure 6A (left panel), the Pax7 mRNA was indeed
knocked down in the TA muscles after Pax7 siRNA injection.
Because most of the Pax7+ cells were MPCs at this stage, this
result suggested that siRNA could be effectively delivered into
these MPCs. Similarly, the Pax3/7BPmRNA was also effectively236 Cell Stem Cell 11, 231–241, August 3, 2012 ª2012 Elsevier Inc.knocked down in TA muscles by this approach (Figure 6A, right
panel). Consistent with a key role of Pax7 in postnatal muscle
growth (Kuang et al., 2006), we found that knockdown of Pax7
reduced the total mass of TA muscles in young mice by about
35% (Figure 6B). Importantly, knockdown of Pax3/7BP also
reduced the weight of the TA muscles to a similar extent. This
result implied that knockdown of Pax3/7BP may reduce the
size of myofibers in young mice. To directly test this, we stained
for laminin on the cross-sections of TA muscles of youngmice to
visualize individual myofibers and measured their sizes (i.e.,
cross-sectional area or CSA). As shown in Figures 6C and 6D,
knockdown of Pax3/7BP reduced the percentage of large myo-
fibers (i.e., those with CSA R 1,000 mm2) with a concomitant
increase in the percentage of smaller myofibers (i.e., those with
CSA % 999 mm2). Moreover, we found that the number of
Pax7+ MPCs also decreased when Pax3/7BP was knocked
down (Figures 6C and 6E). As a control, we also examined
whether knockdown of Pax3/7BP affected the proliferation of
Pax7+ MPCs in adult mice. Four-week-old dystrophin null (i.e.,
mdx) mice were used because their trunk and limb muscles
are known to contain a large number of proliferating Pax7+
MPCs due to cycles of spontaneous myofiber degeneration
and regeneration (Durbeej and Campbell, 2002; Watchko et al.,
2002). We separately electroporated GFP siRNA and Pax3/
7BP siRNA into TA muscles of mdx mice on each side, and we
showed that the endogenous Pax3/7BP could be effectively
knocked down (Figure S5A). However, the number of Pax7+
MPCs was similar between TA muscles treated with GFP siRNA
or Pax3/7BP siRNA (Figures S5B, S5C), suggesting that Pax3/
7BP is dispensable for the proliferation of MPCs in adult
muscles. Collectively, our data suggested that Pax3/7BP was
mainly required for the proliferation of MPCs in vivo in young
mice.
Pax7 and Pax3/7BP Regulate the Expression
of Id3 and Cdc20 in MPCs
We showed above that both Pax7 and Pax3/7BP were required
for the proliferation of MPCs. However, the underlying molecular
mechanisms remained unclear. A recent report showed that
Id3 is a direct target of Pax7 (Kumar et al., 2009). Using primary
myoblasts from P5 mice combined with siRNA knockdown and
chromatin immunoprecipitation (ChIP) assays, we confirmed
that Pax7 was indeed recruited to the Id3 promoter and that
knockdown of Pax7 reduced the expression of Id3 (Figures 7A
and 7B). Knockdown of Pax3/7BP also reduced the expression
of Id3 to a similar extent, suggesting that Pax3/7BP facilitates
Pax7 to regulate Id3 (Figure 7B). To directly test whether knock-
down of Pax3/7BP affected the recruitment of Pax7 or the H3K4
HMT to the Id3 promoter, we infected primary myoblasts with
adenoviruses expressing shRNAs against either lacZ or Pax3/
7BP. By ChIP assays, we found that the recruitment of the
H3K4 HMT, but not Pax7, to the Id3 promoter was clearly
reduced when Pax3/7BP was knocked down (Figure 7C).
Consistently, we also found that there was much less trimethy-
lated H3K4 at the Id3 promoter when Pax3/7BP was knocked
down (Figure 7D). In contrast, the levels of trimethylated H3K4
at the myogenin promoter were not affected by knockdown of
Pax3/7BP (Figure 7D) (Rampalli et al., 2007), suggesting that
Pax3/7BP is only required for the recruitment of the H3K4 HMT
Figure 6. Pax3/7BP Is Required for the Proliferation of Pax7+ MPCs In Vivo
(A–E) Different siRNAs were repeatedly injected into TA muscles of young mice at P6, P8, and P10. For each mouse, one leg was injected with Pax7 or Pax3/7BP
siRNA, while the contralateral leg was injected with GFP siRNA. The TA muscles were isolated at P12 for further analysis.
(A) Total RNA was harvested from TA muscles and the mRNA levels of Pax7 or Pax3/7BP were analyzed by RT-qPCR.
(B) The TA muscles were isolated and weighed and the fold change was calculated as the ratio of the weight of muscles injected with Pax7 siRNA or Pax3/7BP
siRNA over that with GFP siRNA.
(C) TA muscle sections were analyzed by immunostaining. The nuclei were counterstained with DAPI. Scale bar: 100 mm.
(D) The cross-sectional area (CSA) of individual myofibers was measured using PhotoShop software. Myofibers with similar CSA were grouped and their
percentages were calculated and presented. About 2,000 myofibers were examined.
(E) The number of Pax7+ cells was counted in each microscopic field under a 203 objective lens. For each mouse, one microscopic field from each of the five
consecutive slides was analyzed. The fold change was calculated as the ratio of the number of Pax7+ cells from TA muscles treated with Pax3/7BP siRNA over
that with GFP siRNA. In (A and B), 12 mice were treated with the Pax7 siRNA, while 11 were treated with the Pax3/7BP siRNA. In (C)–(E), 18 mice were used. The
data were presented as mean ± SD. *p < 0.05; **p < 0.01. See also Figure S5.
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the effect of Pax3/7BP knockdown on Id3 gene expression
paralleled that of Pax7 knockdown, it did not necessarily mean
that they work together. To further prove that Pax7 regulates
Id3 through Pax3/7BP, we carried out a Pax7-dependent
reporter assay in C2C12 myoblasts with a luciferase reporter
gene under the control of a 934 bp proximal Id3 promoter (Kumar
et al., 2009). As shown in Figure 7E, the Id3 reporter was indeed
activated by cotransfected Pax7 in a Pax3/7BP-dependent
manner. To directly prove that Id3 was involved in the prolifera-
tion of MPCs, we knocked down Id3 in Pax7+ MPCs (Figure 7G,
right panel) and examined BrdU incorporation. As shown in
Figures 7F and 7G (left panel), we found that knockdown of Id3
reduced the incorporation of BrdU, which was indicative of
decreased cell proliferation.
To look for additional target(s) of Pax7 and Pax3/7BP that are
potentially involved in regulating the proliferation of MPCs, we
performed two sets of genome-wide ChIP-sequencing (ChIP-
seq) using antibodies against Pax7 and the trimethylated H3K4
and chromatin isolated from TA muscles of P5 mice. Among
a list of promoter/enhancer fragments that were associated
with both Pax7 and the trimethylated H3K4, we noticed that
one fragment about 9.3 kb upstream of the transcription start
site of Cdc20 contains two closely linked Pax7 binding sites
(Figure S6). Because Cdc20 is a key molecule involved in the
mitotic checkpoint control and cell proliferation (Kim and Yu,C2011; Pesin and Orr-Weaver, 2008), we decided to further
examine this gene. Using ChIP-qPCR, we confirmed that both
Pax7 and the trimethylated H3K4 specifically associated with
this region of Cdc20 (Figure 7H). Using primary myoblasts of
young mice, we confirmed that knockdown of either Pax7 or
Pax3/7BP decreased the expression of Cdc20 (Figure 7I). Finally,
using ChIP assays and chromatin prepared from primary
myoblasts infected with GFP-expressing or Flag-Pax3/7BP-
expressing adenoviruses, we directly proved that Pax3/7BP
was indeed recruited to the regulatory sites in Id3 and Cdc20
that were bound by Pax7 and the trimethylated H3K4 (Figure 7J).
DISCUSSION
Pax3/7BP Facilitates the Recruitment of HMT by Pax7
and Pax3
To understand the functions of Pax7 in MSCs/MPCs, it is impor-
tant to identify its interacting proteins. Unfortunately, very little is
known about Pax7-interacting proteins. A recent breakthrough
in this area came when Pax7 was shown to recruit the H3K4
HMT complex via Wdr5 (McKinnell et al., 2008). However, it is
unclear how Pax7 recruits Wdr5. As an important epigenetic
regulator, the MLL/Set complex itself does not recognize
specific sequences in the promoter/enhancer regions of its
target genes. Instead, it is recruited to these regions via
sequence-specific transcription factors (Ruthenburg et al.,ell Stem Cell 11, 231–241, August 3, 2012 ª2012 Elsevier Inc. 237
Figure 7. Pax3/7BP Facilitates Pax7 to Directly Regulate Id3 and Cdc20
(A) Primary myoblasts freshly isolated from P5 mice were subjected to ChIP analysis. The input genomic DNA and the immunoprecipitated DNA fragments were
subjected to PCR to amplify the Pax7 binding site in the Id3 promoter.
(B) Total RNAwas isolated from primary myoblasts transfected with various siRNAs and subjected to quantitative (q) PCR analysis. ThemRNA levels of Id3, Pax7,
and Pax3/7BP in cells treated with Pax7 siRNA or Pax3/7BP siRNA over that treated with GFP siRNA was calculated and presented.
(C and D) Primary myoblasts from P5 mice were infected with adenoviruses expressing shRNAs targeting LacZ or Pax3/7BP. Thirty-six hours after infection, the
cells were harvested and analyzed by ChIP assays. The Pax7 binding site (C) and the trimethylated H3K4 binding sites (D) in the Id3 andmyogenin promoters (D)
were amplified by qPCR.
(E) C2C12 myoblasts were cotransfected with an Id3-luc reporter together with various plasmids and siRNAs as indicated. Twenty-four hours after transfection,
the WCE was subjected to luciferase assays. The fold change was calculated as the ratio of luciferase activities in experimental samples over that in control cells
transfected with an empty vector and GFP siRNA.
(F and G) Primary myoblasts were transfected with siRNAs against Id3 or GFP. Twenty-four hours after transfection, one batch of cells was labeled by BrdU and
immunostained with an anti-BrdU antibody (F), while the other was subjected to RT-qPCR tomeasure the relativemRNA levels for Id3 (G, right panel). The percent
of BrdU+ cells over DAPI+ cells was calculated and is presented in (G) (left panel). Scale bar: 100 mm.
(H) ChIP-qPCR was performed on chromatin from P5 muscles to confirm the ChIP-seq result.
(I) Primary myoblasts were transfected with various siRNAs and cultured for another 30 hr. The WCE was prepared and subjected to WB analysis.
(J) Primary myoblasts were infected with GFP-expressing or Flag-Pax3/7BP-expressing adenoviruses. Thirty-six hours after infection, chromatin was isolated
and subjected to ChIP-qPCR using the anti-Flag antibody. The Pax7 binding sites in the Id3 and Cdc20 promoters were amplified by qPCR. The fold enrichment
was calculated with the amount of DNA obtained either with a specific antibody over that with a control IgG (C, D, and H) or with the anti-Flag antibody from
Flag-Pax3/7BP-expressing cells over that fromGFP-expressing cells (J). The data in (B)–(E), (G), (H), and (J) were presented asmean ± SD. Ab, antibody. See also
Figure S6.
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Pax3/7BP Bridges Pax3/7 and Wdr52007). Some transcription factors directly recruit this complex
by interacting with specific components of this complex. For
example, Oct4 was recently shown to recruit H3K4 HMT via its
specific interaction with Wdr5 (Ang et al., 2011), while both
AP2d and MEF2D recruit this complex by specifically interacting
with Ash2L (Rampalli et al., 2007; Tan et al., 2008). Other tran-
scription factors recruit the H3K4 HMT via unique adaptor
proteins. For example, Pax2, another member of the Pax family
proteins, recruits the H3K4 HMT via PTIP to regulate its target
gene expression (Patel et al., 2007). Interestingly, like Pax3/238 Cell Stem Cell 11, 231–241, August 3, 2012 ª2012 Elsevier Inc.7BP, PTIP is also a ubiquitously expressed nuclear protein and
facilitates the recruitment of the HMT complex to target gene
promoters by interacting with specific transcription factors
(Mun˜oz and Rouse, 2009; Patel et al., 2007). It remains unclear
which component of the H3K4 HMT complex directly associates
with PTIP. Our work here shows that Pax7 does not directly
recruit the H3K4 HMT. Instead, Pax3/7BP serves as a critical
adaptor to link Wdr5 with Pax7. Even though we found that
Pax3/7BP directly interacts with Wdr5 using in vitro translated
proteins, it remains possible that Pax3/7BP does so via another
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Pax3/7BP Bridges Pax3/7 and Wdr5bridging molecule. More detailed study is needed to understand
the structural basis underlying the interaction between Pax7
and Pax3/7BP as well as that between Pax3/7BP and Wdr5.
A More General Role of Pax3/7BP in Metazoa
Unlike Pax7 or Pax3, Pax3/7BP is ubiquitously expressed and
well conserved in metazoa, suggesting that Pax3/7BP has other
Pax3/7-independent functions. We found that the Pax3/7BP-
associated H3K4 HMT activity is readily detectable not only in
myoblasts but also in nonmuscle cell lines (Figure S2B). There-
fore, it is likely that Pax3/7BP can link the H3K4 HMT with tran-
scription factors other than Pax7 in nonmuscle cells. A search
for Pax3/7BP-interacting proteins may identify such transcrip-
tion factors. Furthermore, it remains to be established whether
Pax3/7BP has additional functions other than transcriptional
regulation.
The Role of Pax7 and Pax3/7BP in the Proliferation
of MPCs
An unexpected recent finding revealed that mouse Pax7 only
plays a crucial role during the first 3 weeks after birth (Lepper
et al., 2009), a period when Pax7+ MPCs are known to undergo
extensive proliferation (Buckingham and Relaix, 2007; Charge´
and Rudnicki, 2004; Le Grand and Rudnicki, 2007). However,
the exact functions of mouse Pax7 in the perinatal period remain
unclear. Here, we showed that Pax7 regulates the proliferation of
MPCs at this stage, which was supported by data from other
groups (Chen et al., 2010; Oustanina et al., 2004; Palacios
et al., 2010; Relaix et al., 2006). Importantly, Pax3/7BP also func-
tions in MPCs from young mice, because knockdown of Pax3/
7BP inhibits the proliferation of Pax7+ MPCs from young mice
both in vitro and in vivo. In contrast, knockdown of Pax3/7BP
has no effect on the proliferation of MPCs in adult muscles.
This is consistent with the fact that Pax7 becomes dispensable
in MSCs/MPCs of adult muscles (Lepper et al., 2009). Presum-
ably, other mechanisms have compensated for the roles of
Pax7 and Pax3/7BP in adult MSCs/MPCs. In addition to Pax7,
we showed that Pax3/7BP also interacts with Pax3, a close
paralog of Pax7 with overlapping functions in a subset of
MSCs/MPCs (Relaix et al., 2005, 2006). Like Pax7, Pax3 also
depends on Pax3/7BP to recruit the H3K4 HMT. This suggests
that, in addition to regulating the proliferation of MPCs, Pax3/
7BP may also participate in processes uniquely controlled by
Pax3, such as migration of MPCs from the hypaxial dermomyo-
tome to limbs during embryonic myogenesis (Buckingham and
Relaix, 2007).
As to the molecular mechanisms underlying the Pax7 and
Pax3/7BP-mediated MPC proliferation, we showed that both
Id3 and Cdc20 are direct target genes of Pax7 and that
Pax3/7BP facilitates Pax7 to recruit the H3K4 HMT to the regu-
latory regions in these genes. Id3 is expressed in both the
quiescent MSC and proliferating MPC population and its over-
expression in C2C12 cells enhances myoblast proliferation but
inhibits differentiation (Atherton et al., 1996; Kumar et al., 2009).
Moreover, we directly demonstrated that knockdown of Id3
decreases the proliferation of Pax7+ MPCs (Figures 7F and
7G). As for Cdc20, a key regulator of the mitotic checkpoint,
its role in cell proliferation is well established (Kim and Yu,
2011; Pesin and Orr-Weaver, 2008). In agreement with our find-Cings, Cdc20 was recently found to be expressed in quiescent
MSCs and was further induced in proliferating MPCs (Pallafac-
china et al., 2010). With more detailed analysis of our ChIP-seq
data, we expect to identify additional direct targets of Pax7 and
Pax3/7BP that could participate in the proliferation of MPCs in
perinatal mice.EXPERIMENTAL PROCEDURES
In Vivo siRNA Delivery
To deliver siRNA into the TA muscles of young mice, 6 ml of siRNA (50 mM)
was first mixed with 24 ml of Opti-MEM medium, while 6 ml of lipofectamine
RNAiMAX was diluted with 24 ml of Opti-MEM for 5 min. Then, the two parts
weremixed for another 20min. The siRNA/RNAiMAXmixtures were repeatedly
injected into the TA muscles of young mice. For each mouse, one leg was
injected with an experimental siRNA, while the contralateral leg was injected
with a control GFP siRNA. At postnatal days 6, 8, and 10, the injection volume
for each TA muscle was 10 ml, 10 ml, and 15 ml, respectively. The TA muscles
were isolated for further analysis at P12. To deliver siRNA into adult mdx
mice, the TA muscles of 4-week-old mdx mice were pretreated with 30 ml of
hyaluronidase (0.4 U/ml) (Sigma) 2 hr before siRNA injection. For each TA
muscle, 6 ml of siRNA (50 mM) was diluted with 0.9% NaCl to a final volume
of 30 ml, and injected into the TA muscle and followed with electroporation
using a BTX ECM 830 generator (mode: LV; field strength: 175V/cm; pulse
length: 20 ms; number of pulses: 8) and a pair of 7 mm Tweezertrodes (BTX)
with one electrode attached to the TA muscle and the other to the gastrocne-
mius muscle. The siRNA injection/electroporation was repeated every 24 hr
for 5 days.
In Vitro HMT Assays
In a final reaction volume of 30 ml, the immune complex, which was pulled
down with specific antibodies and Protein A/G beads, was incubated at
30C for 2 hr in a reaction buffer containing 50 mM Tris-HCl [pH 8.5],
100 mM NaCl, 10 mM DTT, 1 mM 3H-labeled S-adenosyl-L-methionine (3H-
SAM, PerkinElmer, Boston, MA), and 2 mg of recombinant histone H3.1
(NEB, Ipswich, MA). The reaction was stopped by the addition of SDS sample
loading buffer, and the HMT reaction products were then separated on 15%
SDS-PAGE. The gel was incubated with the Amplify Fluorographic Reagent
(GE Healthcare), dried, and subjected to autofluorography. To visualize the
recombinant histone protein used in HMT reactions, the dried gel was rehy-
drated and stained with Coomassie blue.
ChIP Assays and ChIP-Seq
ChIP assays were performed using a standard protocol. Briefly, in primary
myoblasts or muscle tissues from P5 mice, after crosslinking of proteins to
DNA with 1% formaldehyde followed by cell lysis and sonication to generate
chromatin fragments with an average size of 200–300 bp, immunoprecipitation
was performed with 5 mg of the anti-Pax7 or the anti-trimethylated H3K4
antibody bound to Protein A/G-Sepharose beads. After extensive washing
and reversal of crosslinking, proteinase K and RNase A digestion, chromatin
fragments were purified by phenol chloroform extraction, and ethanol pre-
cipitation was performed. For regular ChIP assays, the purified DNA was
amplified by qPCR. For ChIP-seq, we used a protocol from Illumina Inc. Briefly,
the purified DNA (10 ng) was end-repaired, and A-nucleotide overhangs were
added by incubation with the Taq Klenow fragment lacking exonuclease
activity. After the attachment of anchor sequences, fragments were PCR
amplified using Illumina-supplied primers. The purified DNA library products
were evaluated using Bioanalyzer (Agilent) and SYBR qPCR and diluted to
10 nM for cluster generation in situ on the GAIIx paired-end flow cell using
the CBot automated cluster generation system, along with massively parallel
sequencing (2 3 50 bp) on GAIIx. After sequencing, we employed a data
analysis pipeline CASAVA 1.8 (Illumina) to perform the initial bioinformatic
analysis including base calling. The raw sequence reads were aligned
against the unmasked mouse genome (mm9) using SOAP2 with two
mismatches allowed. MACS (v1.4.1) (Zhang et al., 2008) was subsequently
used for genome-wide identification of Pax7 binding sites or DNA sequencesell Stem Cell 11, 231–241, August 3, 2012 ª2012 Elsevier Inc. 239
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Pax3/7BP Bridges Pax3/7 and Wdr5associated with the trimethylated H3K4, with the IgG pulldown as negative
control and a False Discovery Rate (FDR) below 0.05.
Statistical Analysis
To evaluate the statistical significance, the Student’s t test was employed to
analyze the experimental data sets.
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